Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
10.85
-0.23 (-2.08%)
At close: Nov 19, 2026, 4:00 PM EST
10.91
+0.06 (0.55%)
After-hours: Nov 19, 2026, 5:21 PM EST
Neogen Revenue
Neogen had revenue of $222.80M in the quarter ending August 31, 2026, with 6.50% growth. This brings the company's total for the last twelve months to $883.99M, down -0.33% year-over-year. In the fiscal year ending May 31, 2026, Neogen had annual revenue of $870.40M, down -2.72%. That makes Neogen the 8,206th largest company in the world by revenue and 1,872nd in the United States.
Revenue (ttm)
$883.99M
Revenue Growth
-0.33%
P/S Ratio
2.75
Revenue / Employee
$335,357
Employees
2,636
Market Cap
2.37B
Revenue by Segment
Fiscal year ended May 31, 2026 See the full Neogen breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2026 | 870.40M | -24.30M | -2.72% |
| May 31, 2025 | 894.70M | -29.50M | -3.19% |
| May 31, 2024 | 924.20M | 101.75M | 12.37% |
| May 31, 2023 | 822.45M | 295.29M | 56.01% |
| May 31, 2022 | 527.16M | 58.70M | 12.53% |
| May 31, 2021 | 468.46M | 50.29M | 12.03% |
| May 31, 2020 | 418.17M | 3.98M | 0.96% |
| May 31, 2019 | 414.19M | 16.26M | 4.09% |
| May 31, 2018 | 397.93M | 36.34M | 10.05% |
| May 31, 2017 | 361.59M | 40.32M | 12.55% |
| May 31, 2016 | 321.28M | 38.20M | 13.50% |
| May 31, 2015 | 283.07M | 35.67M | 14.42% |
| May 31, 2014 | 247.41M | 39.88M | 19.22% |
| May 31, 2013 | 207.53M | 23.48M | 12.76% |
| May 31, 2012 | 184.05M | 11.36M | 6.58% |
| May 31, 2011 | 172.68M | 32.17M | 22.90% |
| May 31, 2010 | 140.51M | 21.79M | 18.35% |
| May 31, 2009 | 118.72M | 16.30M | 15.92% |
| May 31, 2008 | 102.42M | 16.28M | 18.90% |
| May 31, 2007 | 86.14M | 13.71M | 18.92% |
| May 31, 2006 | 72.43M | 9.68M | 15.42% |
| May 31, 2005 | 62.76M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Enovis | 2.31B |
| CONMED | 1.37B |
| Lumexa Imaging Holdings | 1.06B |
| Inspire Medical Systems | 880.94M |
| iRhythm Holdings | 854.04M |
| TransMedics Group | 727.65M |
| UFP Technologies | 649.52M |
| Axogen | 266.93M |
NEOG News
- 16 days ago - Neogen® To Participate in 2026 UBS Global Healthcare Conference - Business Wire
- 6 weeks ago - Neogen plans to boost R&D investment by roughly 50% in FY27 - TheFly
- 6 weeks ago - Neogen Outlines Strategy for Growth, Innovation and Margin Expansion at 2026 Investor Day - Business Wire
- 6 weeks ago - Neogen Transcript: Investor Day 2026 - Transcripts
- 6 weeks ago - Neogen Slides: FY 2026 - Filings
- 6 weeks ago - Neogen Press release: FY 2026 - Filings
- 6 weeks ago - Neogen Earnings Call Transcript: Q1 2027 - Transcripts
- 6 weeks ago - Neogen Earnings release: Q1 2027 - Filings